General
Australian experts back AstraZeneca vaccine, despite European regulator not ruling out link to rare blood clots
Australian experts have voiced their support for the continued nationwide rollout of AstraZeneca’s COVID-19 vaccine, despite the European medicines regulator concluding there is a “possible link” between the jab and a number of rare blood clots.
The European Medicines Agency (EMA) found in its preliminary review that while the overall risk of clotting in people who’ve been vaccinated is on par with the general population, it could not rule out a potential link with a number of rare clots associated with low blood platelets.
These rare clots were almost all in women under 55, a group that is typically not at a high risk of clotting.
However, the EMA said the benefits of the vaccine “still outweigh the risks”.
-
Noosa News22 hours agoUrgent warning to locals as multiple crews battle major industrial fire at Rocklea in Brisbane’s south
-
Noosa News24 hours agoSurfer attacked by Great White shark off northern NSW coast
-
Noosa News22 hours agoDr Vahid Reza Adib gives evidence at first day of inquest into the death of his patient Rosemarie Campbell
-
General24 hours agoCronulla Sharks captain Cameron McInnes to miss remainder of 2025 with second ACL rupture